To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Cardioverter Defibrillator Device Market size was valued at USD 11.19 billion in 2019 and is poised to grow to USD 20.8 billion by 2031, growing at a CAGR of 7.2% in the forecast period (2024-2031).

cardioverter defibrillator devices market is highly competitive. Implantable cardioverter defibrillator key market players are Medtronic PLC, Abbott Laboratories, and Boston Scientific Corporation. Koninklijke Philips N.V., Cardiac Science Corporation, and Zoll Medical Corporation are leading the external defibrillator market. Key players undergo mergers and acquisitions to produce innovative products. They also focus on strengthening their position in the market. 'Medtronic plc', 'Abbott Laboratories', 'Boston Scientific Corporation', 'Biotronik SE & Co. KG', 'Koninklijke Philips N.V.', 'LivaNova PLC', 'Microport Scientific Corporation', 'Nihon Kohden Corporation', 'Progetti Srl', 'Schiller AG', 'Zoll Medical Corporation (a subsidiary of Asahi Kasei Corporation)', 'Stryker Corporation', 'Defibtech, LLC', 'Cardiac Science Corporation', 'Physio-Control International (a subsidiary of Stryker Corporation)', 'CU Medical Systems, Inc.', 'Fukuda Denshi Co., Ltd.', 'Mindray Medical International Limited', 'Welch Allyn, Inc. (a subsidiary of Hill-Rom Holdings, Inc.)', 'Cardionet (a subsidiary of BioTelemetry, Inc.)'

Defibrillators have improved in terms of cost, size reduction, and ease of operation. The advancement in technology is as follows- automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices are effective in controlling cardiac attack conditions. Due to technological advancements in defibrillators, the operating defibrillator has become easy for an observer post-induction of proper training. In April 2019, Biotronik, a Medical Device Company launched the Acticor device family of new implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillator (CRT-Ds).

Smart pacemaker is a device that can detect even the smallest irregularity in the functioning of the heart. Smart pacemakers rectify the abnormalities in the heart and reestablish normal body function. It also alerts the patients as well as physicians about the patient's cardiac health. This feature of the smart maker helps to decrease the mortality rate.

North America is expected to hold the largest market share during the forecast period due to initiatives taken by key players, favorable regulations, and advanced technological facilities in the U.S and Canada.

Feedback From Our Clients

Global Cardioverter Defibrillator Device market

Product ID: SQMIG35A2207